BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 17192847)

  • 21. Anandamide induces matrix metalloproteinase-2 production through cannabinoid-1 receptor and transient receptor potential vanilloid-1 in human dental pulp cells in culture.
    Miyashita K; Oyama T; Sakuta T; Tokuda M; Torii M
    J Endod; 2012 Jun; 38(6):786-90. PubMed ID: 22595113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: involvement of both mitochondrial and death receptor pathways.
    Costa MA; Fonseca BM; Teixeira NA; Correia-da-Silva G
    Placenta; 2015 Jan; 36(1):69-76. PubMed ID: 25465706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis.
    Cozzolino R; Calì G; Bifulco M; Laccetti P
    Invest New Drugs; 2010 Apr; 28(2):115-23. PubMed ID: 19189054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.
    Kunimasa K; Ikekita M; Sato M; Ohta T; Yamori Y; Ikeda M; Kuranuki S; Oikawa T
    Cancer Sci; 2010 Nov; 101(11):2462-9. PubMed ID: 20670297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of anandamide on polyamine levels and cell growth in human colon cancer cells.
    Linsalata M; Notarnicola M; Tutino V; Bifulco M; Santoro A; Laezza C; Messa C; Orlando A; Caruso MG
    Anticancer Res; 2010 Jul; 30(7):2583-9. PubMed ID: 20682986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Kokona D; Thermos K
    Exp Eye Res; 2015 Jul; 136():45-58. PubMed ID: 25989217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of the endocannabinoid system in periodontal healing.
    Kozono S; Matsuyama T; Biwasa KK; Kawahara K; Nakajima Y; Yoshimoto T; Yonamine Y; Kadomatsu H; Tancharoen S; Hashiguchi T; Noguchi K; Maruyama I
    Biochem Biophys Res Commun; 2010 Apr; 394(4):928-33. PubMed ID: 20233580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling.
    Soliman E; Van Dross R
    Mol Carcinog; 2016 Nov; 55(11):1807-1821. PubMed ID: 26513129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticancer activity of anandamide in human cutaneous melanoma cells.
    Adinolfi B; Romanini A; Vanni A; Martinotti E; Chicca A; Fogli S; Nieri P
    Eur J Pharmacol; 2013 Oct; 718(1-3):154-9. PubMed ID: 24041928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of endocannabinoids in the regulation of luteinizing hormone and prolactin release. Differences between the effects of AEA and 2AG.
    Oláh M; Milloh H; Wenger T
    Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S36-40. PubMed ID: 18308464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
    Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
    Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts.
    DeMorrow S; Glaser S; Francis H; Venter J; Vaculin B; Vaculin S; Alpini G
    J Biol Chem; 2007 Apr; 282(17):13098-113. PubMed ID: 17329257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new strategy to block tumor growth by inhibiting endocannabinoid inactivation.
    Bifulco M; Laezza C; Valenti M; Ligresti A; Portella G; DI Marzo V
    FASEB J; 2004 Oct; 18(13):1606-8. PubMed ID: 15289448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis.
    Pisanti S; Picardi P; Prota L; Proto MC; Laezza C; McGuire PG; Morbidelli L; Gazzerro P; Ziche M; Das A; Bifulco M
    Blood; 2011 May; 117(20):5541-50. PubMed ID: 21460248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The endocannabinoid anandamide induces apoptosis of rat decidual cells through a mechanism involving ceramide synthesis and p38 MAPK activation.
    Fonseca BM; Correia-da-Silva G; Teixeira NA
    Apoptosis; 2013 Dec; 18(12):1526-35. PubMed ID: 24048885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paeonol exerts anti-angiogenic and anti-metastatic activities through downmodulation of Akt activation and inactivation of matrix metalloproteinases.
    Kim SA; Lee HJ; Ahn KS; Lee HJ; Lee EO; Ahn KS; Choi SH; Jung SJ; Kim JY; Baek N; Kim SH
    Biol Pharm Bull; 2009 Jul; 32(7):1142-7. PubMed ID: 19571375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.
    Khasabova IA; Khasabov S; Paz J; Harding-Rose C; Simone DA; Seybold VS
    J Neurosci; 2012 May; 32(20):7091-101. PubMed ID: 22593077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis.
    Bari M; Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
    J Biol Chem; 2005 Apr; 280(13):12212-20. PubMed ID: 15657045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex.
    Rubino T; Realini N; Castiglioni C; Guidali C; Viganó D; Marras E; Petrosino S; Perletti G; Maccarrone M; Di Marzo V; Parolaro D
    Cereb Cortex; 2008 Jun; 18(6):1292-301. PubMed ID: 17921459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms.
    Starowicz K; Makuch W; Osikowicz M; Piscitelli F; Petrosino S; Di Marzo V; Przewlocka B
    Neuropharmacology; 2012 Mar; 62(4):1746-55. PubMed ID: 22178705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.